Published in Stat Med on December 21, 1994
Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ (1999) 3.12
Trials and fast changing technologies: the case for tracker studies. BMJ (2000) 2.46
Bayesian statistical methods. BMJ (1996) 1.27
How much can we learn about missing data?: an exploration of a clinical trial in psychiatry. J R Stat Soc Ser A Stat Soc (2010) 1.10
Strategy for randomised clinical trials in rare cancers. BMJ (2003) 1.08
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. J Clin Oncol (2009) 0.84
Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiol (2012) 0.79
A statistical framework for quantifying clinical equipoise for individual cases during randomized controlled surgical trials. Trials (2011) 0.77
A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer. Br J Cancer (2002) 0.77
What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council. Br J Cancer (1998) 0.75
Assurance calculations for planning clinical trials with time-to-event outcomes. Stat Med (2013) 0.75
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemp Clin Trials Commun (2017) 0.75
Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial. Trials (2016) 0.75
Bayesian analysis of a mastitis control plan to investigate the influence of veterinary prior beliefs on clinical interpretation. Prev Vet Med (2009) 0.75
A Bayesian elicitation of veterinary beliefs regarding systemic dry cow therapy: variation and importance for clinical trial design. Prev Vet Med (2012) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Laparoscopic versus open inguinal hernia repair: randomised prospective trial. Lancet (1994) 6.91
Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. BMJ (1998) 5.96
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol (1994) 5.02
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med (1995) 3.71
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med (1991) 2.76
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet (2004) 2.63
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Mapping the densities of malaria vectors within a single village. Acta Trop (1995) 2.31
Statistical methodology for evaluating gastrointestinal symptoms. Clin Gastroenterol (1985) 2.29
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Probabilistic prediction in patient management and clinical trials. Stat Med (1987) 2.10
Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J (1995) 2.09
Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol (1992) 1.99
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials (1989) 1.79
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med (1991) 1.55
Risk stratification for open heart surgery. BMJ (1992) 1.51
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ (1992) 1.46
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
A database on dyspepsia. Gut (1994) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Application of Bayesian statistics to decision making during a clinical trial. Stat Med (1992) 1.35
Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res (2003) 1.35
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Computer aided decision making in medicine. Br Med J (Clin Res Ed) (1984) 1.24
Effects of an ambient air pollution intervention and environmental tobacco smoke on children's respiratory health in Hong Kong. Int J Epidemiol (1996) 1.23
Approximate cross-validatory predictive checks in disease mapping models. Stat Med (2003) 1.22
Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil (1997) 1.19
Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset. Clin Exp Immunol (1985) 1.18
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
Survival analysis in observational studies. Stat Med (1997) 1.17
The what, why and how of Bayesian clinical trials monitoring. Stat Med (1994) 1.16
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Estimation of population pharmacokinetics using the Gibbs sampler. J Pharmacokinet Biopharm (1995) 1.14
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
An analysis of repeated biopsies following cardiac transplantation. Stat Med (1984) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Using routine intelligence to target inspection of healthcare providers in England. Qual Saf Health Care (2009) 1.12
Evaluation of a diagnostic algorithm for heart disease in neonates. BMJ (1991) 1.11
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Breast cancer in thyroid disease: fact or fallacy? Lancet (1981) 1.08
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05
Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med (1988) 1.03
Comparison between two districts of the effects of an air pollution intervention on bronchial responsiveness in primary school children in Hong Kong. J Epidemiol Community Health (1998) 1.02
A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol (1978) 1.02
Evaluation of clinical decision-aids, with an application to a system for dyspepsia. Stat Med (1984) 1.02
How does computer-aided diagnosis improve the management of acute abdominal pain? Ann R Coll Surg Engl (1992) 1.02
Changing patterns of coeliac disease frequency: an analysis of Coeliac Society membership records. Gut (1985) 1.00
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr (2013) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99
Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol (1993) 0.99
Changes in human serum dopamine- -hydroxylase activity with age. Nature (1972) 0.98
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Bayesian design and analysis of two x two factorial clinical trials. Biometrics (1997) 0.98
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
Limitations of mortality data as a guide to comparative lung cancer incidence within an urban area. Public Health (1979) 0.97
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97